C21 Investments (CXXIF) Research & Development (2018 - 2024)

C21 Investments (CXXIF) has reported Research & Development for 7 consecutive years, with $61189.0 the latest figure, recorded in Q3 2024.

• On a quarterly basis, Research & Development changed N/A year-over-year to $61189.0 in Q3 2024; TTM through Sep 2024 was $87944.0, a N/A change from a year earlier, with the FY2026 full-year figure at $241063.0, up 16.1% from the prior year.
• Research & Development was $61189.0 for Q3 2024 at C21 Investments, up from $39760.0 in the prior quarter.
• Over five years, Research & Development peaked at $110547.0 in Q1 2020 and troughed at -$36696.0 in Q1 2024.
• A 5-year average of $31510.3 and a median of $23650.5 in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development plunged 92.78% in 2020 and jumped 49.58% in 2021, its largest moves.
• Over 5 years, Research & Development stood at $21636.0 in 2020, then soared by 49.58% to $32363.0 in 2021, then tumbled by 46.86% to $17197.0 in 2022, then advanced by 1.56% to $17465.0 in 2023, then soared by 250.35% to $61189.0 in 2024.
• The last three Research & Development figures came in at $61189.0 (Q3 2024), $39760.0 (Q2 2024), and -$36696.0 (Q1 2024), per Business Quant data.